1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
OBIO® Life Sciences Critical Technologies & Commercialization Program (LSCTC) is sponsored by Ontario Bioscience Innovation Organization (OBIO). The OBIO® Life Sciences Critical Technologies & Commercialization Program (LSCTC) provides infrastructure, commercialization, technology adoption, and talent programming to Ontario small and medium enterprises (SMEs) in the life sciences sector.
It focuses on leveraging critical technologies like ethical AI, blockchain, and robotics to advance made-in-Ontario technologies including therapeutics, diagnostics, medical devices, and digital health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Critical Technologies — OBIO Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence OBIO® is inviting health science companies to apply for the Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence.
The LSCTC Centre will catalyze a globally competitive collaborative ecosystem by leveraging and building on Ontario’s expertise and capabilities to accelerate the health science industry’s use of critical technologies: 5G and advanced networks , ethical artificial intelligence , blockchain , cybersecurity , quantum and robotics .
LSCTC Centre of Excellence The LSCTC Centre of Excellence provides infrastructure, commercialization, technology adoption and talent programming to Ontario small and medium enterprises (SMEs) and emerging ventures to drive intellectual property creation and advance innovative made-in-Ontario technologies, including but not limited to therapeutics, diagnostics, medical devices and digital health.
OBIO® is working with key partners to support life science, medtech and healthtech ventures to ensure Ontario innovation stays competitive in the global market. Scale AI is Canada’s AI Global Innovation Cluster dedicated to building the next-generation supply chain and boosting industry performance by leveraging AI technologies.
A business-led consortium, Scale AI will drive economic growth, bolster Canada’s leadership in the global innovation race, support the building of world-leading businesses, create highly skilled jobs, and accelerate the adoption of AI-powered technologies. Scale AI will contribute to the development of an innovative, competitive, diverse and inclusive Canadian economy, with a focus on Small and Medium Enterprises (SMEs).
Participants will benefit from: Programs with non-dilutive funding streams to support projects related to: i. De-risking of emerging technologies & venture creation, ii. Strengthening technology commercialization, including proof-of-concept, validation, demonstrations to advance product development milestones, and/or iii.
Technology adoption; The LSCTC Centre hub with access to subsidized shared office space (based on availability for OBIO® Members); Early-stage AI development projects can also access funding through ScaleAI; OBIO’s Knowledge Centre, including advisory, market research databases & industry resource library for OBIO® Members; A network of partners with expertise in the critical technologies and health science sector; and/or Business development and commercialization training.
To be eligible to access the LSCTC Centre of Excellence resources, your venture must meet the following criteria: Be either a private health science company based in Ontario, or an emerging venture with intellectual property (IP) developed in Ontario; Focused on developing human health science products/services, including but not limited to medical devices, diagnostics, digital health, health IT and therapeutics; Working to develop, integrate or have integrated at least one critical technology (5G/advanced networks, ethical artificial intelligence, blockchain, cybersecurity, quantum, and/or robotics) into your products, services and/or operations; Committed to the creation and commercialization of made-in-Ontario IP.
To be eligible for non-dilutive funding streams, your venture must meet the following additional stream-specific criteria: i.
De-risking of emerging technologies & venture creation Be either an emerging venture with intellectual property (IP) developed in Ontario, or an early stage, private health science small or medium enterprise (SME) (fewer than 500 paid FTE) based in Ontario; For emerging ventures, high potential for company creation with operations in Ontario; and Seeking support with IP management, company creation, technology de-risking. ii.
Strengthening technology commercialization A private, health science SME based in Ontario; Demonstrates that the technology solves a critical problem and a market exists for the product/service; Company owns or has license agreement(s) in place for intellectual property associated with the technology; Demonstrate that the completed project advances the company toward a significant value creation event; and Provide 2:1 cash matching funds for the overall commercialization project to advance technology proof-of-concept, validation, demonstration, testing, and/or deployment.
Companies may apply to be considered for funding between $25,000 to $50,000 CAD.
A private, health science SME based in Ontario; Successfully completed an initial pilot/validation study with supporting data; A market-ready product/service, ready to commercialize at scale; Raised dilutive funding or generating annual recurring revenues; and Provide 2:1 matching funds for an adoption project to have the technology evaluated by a healthcare organization. Companies may apply to be considered for up to $250,000 CAD.
A private, health science SME based in Canada; Demonstrates the need and intent to implement AI to enhance their product; Demonstrates that the technology solves a critical problem and a market exists for the product/service; This program is reimbursement-based and the maximum funding available for approved projects is $50,000 CAD. Complete and submit your application to join the LSCTC Centre of Excellence network.
One application per company/venture. Application must be submitted by a member of your senior management team. Applications will be reviewed on a rolling basis.
Approved applicants meeting eligibility criteria will be invited to access LSCTC resources and events. Selected applicants will be invited to submit detailed project proposals to the non-dilutive funding streams for further consideration. Successful project proposals will be integrated into a Project Agreement.
Projects may be initiated as early as two months after initial application submission. For more information, please contact lsctc@obio. ca .
Read about success stories and some of the dual-use & defence technology projects that OBIO® is supporting: Projects & Success stories This Centre is funded in part by the Government of Ontario and Scale AI.
According to the current listing, eligibility includes: Private, health science SMEs based in Ontario. Eligibility varies by funding stream, but generally requires demonstration of a critical problem solved by the technology, market existence, intellectual property ownership, and matching funds. Confirm the full requirements in the official notice before applying.
The current listing shows $25,000 to $250,000 CAD (depending on stream). Verify award ceilings, matching requirements, and allowable costs in the official notice.
OBIO® Life Sciences Critical Technologies & Commercialization Program (LSCTC) is funded by Ontario Bioscience Innovation Organization (OBIO). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The FY2026 Bus Safety, Accessibility, and Innovation Research Program closes September 28. Universities, agencies, and startups are all eligible to lead — but every team must include a transit vehicle manufacturer in a prominent role, and FTA already cancelled a nearly identical NOFO in 2024 without making a single award.
Read articleThe FY2026 Agriculture Innovation Center Demonstration Program posted September 9 with a January 31, 2027 deadline. It is the first competition under a rule codified in 2024, the award floor is $600,000, and the single most common way to lose is to upload your application to Grants.gov.
Read articleThe Public Wireless Supply Chain Innovation Fund started at $1.5 billion for open RAN. Congress rescinded $850 million, NTIA canceled Round 3, and what remains is a $53 million final round pointed at AI-native radio access networks — with a $25 million per-project ceiling, a mandatory 50 percent cost share, and rolling awards beginning this fall.
Read article